Kathryn Tucker

Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8 ⁺ T Cell Immunity

Judith E. Epstein, Kavita Tewari, Kirsten E. Lyke et al. · Science · 2011 · 541 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya

Bernhards Ogutu, Odika J. Apollo, Denise McKinney et al. · PLoS ONE · 2009 · 343 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A

Michele Spring, James F. Cummings, Christian F. Ockenhouse et al. · PLoS ONE · 2009 · 208 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya

José A. Stoute, Joash Gombe, Mark R. Withers et al. · Vaccine · 2005 · 100 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-γ/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection

James F. Cummings, Michele Spring, Robert Schwenk et al. · Vaccine · 2009 · 88 citations

Veterinary Medicine, Immunology, Infectious Diseases +17